Andrew Witty
Thursday 11/06/2014
Andrew Witty, chief executive officer of GlaxoSmithKline, weighs the importance of balancing medical innovation with providing public access to medical resources.
The Power of Questions close notice
Andrew Witty, chief executive officer of GlaxoSmithKline, weighs the importance of balancing medical innovation with providing public access to medical resources.